AzTrials
AzTrials

Complementary InvestigationsCEinEDNCT04455087

Analysis of Complementary Exams Prescriptions From an Emergency Unit of a University Hospital

An observational study of Complementary Investigations, run by University of Monastir at 1 site in Tunisia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to evaluate the appropriateness of prescribing additional tests in the emergency unit of the University Hospital of Monastir. Read more about this study

Who is it for?
Ages 1 year and older
Conditions the study is for
Complementary Investigations
What is being tested?
sensitization
How many people
2,000 participants
Where
1 siteTunisia
Study dates
Apr 2013to Feb 2017
How long will I take part?
12 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: all patients consulting urences of Monastir aged more than 1 year

Who may be able to join

  • all patients consulting Emergency Department of Monastir aged more than 1 year

Who cannot join

  • age < 1 year

Trial locations and contacts

1 site in 1 country.

Tunisia1 site
  • Hospital of Fattouma Bourguiba

    Monastir, 5000

Other trials in Tunisia

About this study

Official title: Complementary Exams in Emergency Department

The objective of this study is to evaluate the appropriateness of prescribing additional tests in the emergency unit of the University Hospital of Monastir.

Read the detailed description

The objective of this study is to evaluate the appropriateness of prescribing additional tests in the emergency unit of the University Hospital of Monastir.

Being tested
sensitization
Keywords
complementary exam

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sensitizationOther

    sensitization of doctor to decrease the prescription of abuse exams

Study groups in NCT04455087
Study groupRoleWhat they receive
before intervention1000 patients befor sensitization
Receives: Other: sensitization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The analysis focused on the appropriateness or otherwise of the complementary exams

    Measured: The analysis focused on the appropriateness or otherwise of the complementary exams

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2020
  2. Study startApr 2013
  3. Primary completionJan 2017
  4. Study completionFeb 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2,000 participants (actual)
Target duration
12 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT04455087
Sponsor's protocol ID
complementary exams
Acronym
CEinED
Status last verified
Jun 2020
First submitted
8 Apr 2014
Last updated
2 Jul 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided: not yet

Questions about this trial

What is this clinical trial studying?

An observational study of Complementary Investigations, run by University of Monastir at 1 site in Tunisia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Tunisia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The analysis focused on the appropriateness or otherwise of the complementary exams (time frame: The analysis focused on the appropriateness or otherwise of the complementary exams). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in